Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up

Activation and expansion are essential for success in both autologous and allogeneic therapies.

Development of Gamma-Delta T-Cell Therapies

Continuous manufacturing and a quality-by-design development approach are a natural fit.

QbD for Small-Molecule Continuous Process Development

Topic

Joe Petroziello is Executive Vice President, Head of Global Medical Affairs & Corporate Development at MJH Life Sciences.

Articles

Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.

Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

Krizia M. Karry, PhD, ishead of Global Technical Marketing, Pharma Solutions, BASF.

Brian Carlin is president and owner of Carlin Pharma Consulting LLC.

Nigel Langley, PhD, MBA, is global technical director at Gaylord Life Sciences and Immediate Past Chair, IPEC- Americas.

R. Christian Moreton, PhD, is vice-president of pharmaceutical sciences at Finnbrit Consulting and a member of Pharmaceutical Technology’s editorial advisory board.

David Schoneker is president, Black Diamond Regulatory Consulting, LLC

Katherine L. Ulman is president of KLU Consulting.

Joseph Zeleznik is technical product director, IMCD US

Key information is needed for excipients and their potential impact on continuous manufacturing processes.

Understanding Excipient Characteristics to Ensure Robust Continuous Manufacturing 

Feliza Mirasol is the science editor for 

Syngene's new production platform offers rapid protein synthesis with lower risk.

New Syngene Platform Aims for Rapid Protein Production

At BIO 2024 in San Diego, John Dunlop, PhD, chief scientific officer at Aliada Therapeutics, sat down for an interview with Pharmaceutical Technology to discuss the firm’s MODEL platform and its potential impact on therapeutic delivery for brain-related conditions. 

Therapeutic Delivery for Brain-Related Conditions

CordenPharma has partnered with Spain-based Certest to develop ionizable lipids for LNP formulations.

CordenPharma and Certest Team Up on Ionizable Lipids to Develop LNP Formulations

Webcasts

Webinar Date/Time: Wednesday, July 10, 2024 - 11am EDT | 4pm GMT | 5pm CEST


Simplification of Continuous Tableting for Accelerated Product Development and Lifecycle Flexibility

Raphael Bar, PhD, rbar@netvision.net.il, is a consultant at BR Consulting in Ness Ziona, Israel.

A statistical analysis for determining an expiration date can be applied to replicates or their corresponding averages as suggested in industry guidelines.

Determination of Shelf-Life from Stability Data: From Replicates or from Averages?

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Artificial intelligence and machine learning can help overcome poor solubility and bioavailability.

Using Advanced Algorithms to Solve Formulation Challenges

Videos

Lee Cronin, founder and CEO of Chemify, discusses the combination of digital chemistry, robotics, and AI in the drug discovery space.

The Intersection of Chemistry, Robotics, and AI in Drug Discovery (BIO 2024)

Webinar Date/Time: Thu, Jun 27, 2024 11:00 AM EDT
